Results 191 to 200 of about 1,132,887 (301)

Bipolar Disorder and the Risk of Cardiovascular Diseases: A Systematic Review and Meta‐Analysis of Observational Studies

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Introduction Bipolar disorder (BD) is a chronic psychiatric illness characterized by recurrent manic and depressive episodes, affecting 2% of the global population. It is associated with premature mortality, including cardiovascular disease (CVD)‐related mortality.
Fernando Daibert de Souza Motta, Matheus de Lima Ruffini, Amanda Cunha Ritter, Sofia Moreira Ferrão, Rodrigo Sousa Silva, Nicole da Silva Mastella, Bruno Braga Montezano, Elias Ajub Neto, Flávio Kapczinski, Jairo Vinícius Pinto, Ives Cavalcante Passos   +10 more
wiley   +1 more source

Hepatocellular adenomas associated with antiepileptic drugs: A case report. [PDF]

Radiol Case Rep
Azevedo RP, Tavares RRFM, Ortega CD, Rocha MS.   +3 more
europepmc   +1 more source

Comparative effectiveness, safety and acceptability of pharmacological and psychosocial interventions for the treatment of cannabis use disorder: A network meta‐analysis

Addiction, EarlyView.
Abstract Aim Our primary aim was to conduct a network meta‐analysis (NMA) for the effectiveness, safety and acceptability of all psychosocial interventions and all pharmacotherapies for cannabis use disorder (CUD). Methods We conducted a NMA of studies identified from two completed systematic reviews examining the effectiveness, safety and ...
Monika Halicka, Francesca Spiga, Tom P. Freeman, Suzanne Nielsen, Jelena Savović, Julian P. T. Higgins, Deborah M. Caldwell   +6 more
wiley   +1 more source

Implementation and validation of a 24/7 system for the monitoring of antiepileptic drugs. [PDF]

Front Neurol
Khromov T, Dihazi GH, Brockmeyer P, Fischer A, Streit F.   +4 more
europepmc   +1 more source

Clobazam to preserve meaningful engagement in prolonged disorder of consciousness with concurrent seizure disorder

PM&R, EarlyView.
Tatiana Bernstein, Zachary Miklja, Tiffany Wood, Joshua Startup   +3 more
wiley   +1 more source

Beyond abstinence: Redefining success in cannabis use disorder treatment

Addiction, EarlyView.
Abstract Background Over two decades of pharmacotherapy research has yet to yield a consistently effective medication for cannabis use disorder (CUD), in part because clinical trials have frequently prioritized abstinence as a primary or key endpoint.
Tobias B. Atkin, Frances R. Levin, John Mariani, Christina A. Brezing   +3 more
wiley   +1 more source

Progress report on new epilepsy treatments: A summary of the Eighteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVIII). II. Treatments in more advanced clinical development. [PDF]

Epilepsia
Bialer M, Johannessen Landmark C, Koepp MJ, Perucca E, Perucca P, Tomson T, White HS, Wirrell E.   +7 more
europepmc   +1 more source

Accidental overdose admissions and premature death: A large population‐based data‐linkage cohort study in New South Wales, Australia (PAVLOVA 4)

Addiction, EarlyView.
Abstract Background and aims People with substance use disorders have reduced life‐expectancy; however, risks of premature death from injuries and natural causes following an accidental overdose are not well characterised. This study aimed to estimate risk of premature death (by cause and over time), and disease burden following hospitalised accidental
Firouzeh Noghrehchi, Rose Cairns, Darren M. Roberts, Kirsten C. Morley, Paul S. Haber, Nicholas A. Buckley   +5 more
wiley   +1 more source

Dried Blood Spot Analysis for Simultaneous Quantification of Antiepileptic Drugs Using Liquid Chromatography-Tandem Mass Spectrometry. [PDF]

Rapid Commun Mass Spectrom
Abady MM, Jeong JS, Kwon HJ.
europepmc   +1 more source